Researchers in Kingston, Ont., are embarking upon a clinical trial that will look at whether very small doses of psilocybin — ...

The Kingston Health Sciences Centre Research Institute launched the first-ever Health Canada-approved clinical trial ...

According to results of a phase 2 study of PSX-001, the psilocybin-assisted treatment for generalized anxiety disorder led to ...

Much of the evidence documenting the earliest use of psilocybin in mushrooms for medicinal purposes by the ancient Mayans and Aztecs was destroyed by Spanish missionaries in the 1500s. However, that ...

A single psilocybin dose relieved chronic pain and depression-like symptoms in mice by rebalancing brain circuits that regulate mood and pain.

Reasons to be Cheerful reports on the growing use of psilocybin in mental health treatment, showing promise for conditions ...

(The Center Square) – Mental health care providers are rediscovering new uses for old medicines. Recent findings demonstrating the efficacy of psilocybin, the active ingredient in magic mushrooms, ...

A single dose of psilocybin significantly decreased depression and anxiety in people with cancer, according to a new study. Psilocybin is a chemical in certain mushrooms that causes hallucinogenic ...

A first-of-its-kind Canadian trial is testing psilocybin, the psychedelic component found in magic mushrooms, on participants ...

A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases in anxiety and depression in patients diagnosed with life-threatening cancer ...

DEAR DOCTOR: I see that psilocybin mushrooms — what we used to call magic mushrooms — are being studied now as a possible treatment for post-traumatic stress disorder and depression. I’ve struggled ...

UCLA study finds magic mushrooms can help curb the anxiety of advanced cancer. Sept. 7, 2010— -- When 55-year-old California software developer Pam Sakuda was diagnosed with metastic colon cancer ...